Table 1 Patient demographic characteristics

No. of patients

26

41

N.A.

Age (years)

63.7 ± 16.4 [24, 87]^a

52.9 ± 12.2 [15, 69]^a

0.003

Gender

 Female

8

18

0.315

 Male

18

23

 Weight (kg)

65.2 ± 12.2 [51.2, 110]^a

61.9 ± 12.6 [44, 101.4]^a

0.233

 Height (cm)

166.2 ± 8.6 [150, 184]^a

163.4 ± 9.6 [146, 183]^a

0.289

 BMI

23.5 ± 3.1 [17.3, 32.5]^a

23.0 ± 3.4 [16.3, 31.7]^a

0.570

 Glucose level

5.38 ± 0.88 [4.3, 7.9]^a

5.34 ± 0.84 [3.8, 8.1]^a

0.846

 Injected activity (MBq)

258 ± 46 [200, 407]^a

81 ± 15 [51, 115]^a

< 0.001

 Injected activity/weight(MBq/kg)

3.97 ± 0.28[3.61, 4.75]^a

1.32 ± 0.18[1.10, 2.11]^a

< 0.001

 Uptake time (min)

70 ± 14 [49, 97]^a

68 ± 16 [39, 105]^a

0.458

Primary cancer type

N.A.

 Leukemia

1^b

3^b

 Bladder cancer

1^b

0

 Multiple myeloma

1^b

0

 Lung cancer

6^b

9^b

 Liver cancer

0

1^b

 Laryngeal carcinoma

1^b

0

 Bone tumor

1^b

0

 Colorectal cancer

3^b

2^b

 Lymphoma

5^b

8^b

 Ovarian cancer

1^b

0

 Breast cancer

1^b

2^b

 Renal cancer

1^b

1^b

 Esophageal cancer

2^b

2^b

 Gastric cancer

1^b

0

 Pancreatic cancer

1^b

1^b

 Pelvic carcinoma

0

1^b

 Tongue cancer

0

2^b

 Uterine cancer

0

5^b

 Aplastic anemia

0

1^b

 Popliteal fossa tumor

0

1^b

 Tonsil tumor

0

1^b

 Nasopharyngeal cancer

0

3^b